top of page

Our Team

tperera photo 2_edited.png

Timothy Perera, PhD

Founder & CEO

  • LinkedIn

Tim has more than 30 years global large and small Pharma experience in Target Identification, Drug Discovery and Development.  Before setting up DeuterOncology, Tim was the Founder and CSO of OCTIMET oncology NV.  Prior to that Tim was the Global Discovery Leader for the Lung Disease Area at J&J.   Tim was recognized for the quality of the research and dedication to Janssen R&D by being made a Janssen Research Fellow in 2012.  During his career at JNJ he led multiple discovery projects teams including 4 that reached the clinic.  Tim was the Discovery Project Leader and Project Champion for  the first globally approved FGFR kinase inhibitor Balversa (erdafitinib). Tim is a named inventor on 16 patents and coauthor on more than 40 scientific publications.   



1 Approved drug

16 patents

30 + years experience
in drug discovery

40+ publications


Prof. Jaap Verweij

Chief Medical Officer

  • LinkedIn
Tomas_011 head_edited.png

Tomas Van Dyck

Chief Financial Officer

  • LinkedIn
florence photo high res_edited.png

Florence Wastelin

Director of Operations

  • LinkedIn
hilde new_edited.png

Hilde Windels

Business Development

  • LinkedIn

Desiree Kanters

Clinical Operations

  • LinkedIn
bottom of page